Position paper: Rapid responses to steroids: Current status and future prospects

European Journal of Endocrinology

Volumn 162, Issue 5, 2010, Pages 825-830

  Wendler, Alexandra ^a   Baldi, Elisabetta ^b   Harvey, Brian J ^c   Nadal, Angel ^d   Norman, Anthony ^e   Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FLORENCE   (Italy)

^c BEAUMONT HOSPITAL   (Ireland)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(2 (4 HYDROXYPHENYL) 3 PHENYLPENY 2 ENOIC ACID (4 (2 DIMETHYLAMINOORTHOXY) PHENYL)AMIDE; ALDOSTERONE; ALTHESIN; ANDROGEN; ANTIOBESITY AGENT; BUDESONIDE; ESTROGEN; FLUTICASONE; PROGESTERONE; PROGESTERONE RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; TETRAIODOTHYROACETIC ACID; THYROID HORMONE; THYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE;

ACTION RESEARCH; ASTHMA; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; NOTE; PRIORITY JOURNAL;

ANIMALS; HUMANS; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; STEROIDS;

EID: 77951661764     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1072     Document Type: Note

References (59)

1. Seyle H. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 1942 30 437-453.
2. Pietras RJ & Szego CM. Steroid hormone-responsive, isolated endometrial cells. Endocrinology 1975 96 946-954.
3. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K & Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiological Reviews 2003 83 965-1016. (Pubitemid 36828929)
4. Hammes SR & Levin ER. Extranuclear steroid receptors: nature and actions. Endocrine Reviews 2007 28 726-741.
5. Marino M & Ascenzi P. Steroid hormone rapid signaling: the pivotal role of S-palmitoylation. IUBMB Life 2006 58 716-719. (Pubitemid 46900132)
6. Wehling M, Eisen C & Christ M. Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids. Molecular and Cellular Endocrinology 1992 90 C5-C9.
7. Haseroth K, Gerdes D, Berger S, Feuring M, Gunther A, Herbst C, Christ M & Wehling M. Rapid nongenomic effects of aldosterone in mineralocorticoid- receptor-knockout mice. Biochemical and Biophysical Research Communications 1999 266 257-261. (Pubitemid 30028801)
8. 3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005 146 2864-2871.
9. Akera T. Membrane adenosine triphosphatase: a digitalis receptor? Science 1977 198 569-574.
10. Pick H, Etter S, Baud O, Schmauder R, Bordoli L, Schwede T & Vogel H. Dual activities of odorants on olfactory and nuclear hormone receptors. Journal of Biological Chemistry 2009 284 30547-30555.
11. Belkhadir Y, Wang X & Chory J. Brassinosteroid signaling pathway. Science Signalling 2006 2006 cm4.
12. Lampert J. Neurosteroids: endogenous allosteric modulators of GABA(A) receptors. Psychoneuroendocrinology 2009 34 548-558.
13. Charalampopoulos I, Alexaki VI, Lazaridis I, Dermitzaki E, Avlonitis N, Tsatsanis C, Calogeropoulou T, Margioris AN, Castanas E & Gravanis A. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB Journal 2006 20 577-579. (Pubitemid 46671255)
14. Otto C, Fuchs I, Kauselmann G, Kern H, Zevnik B, Andreasen P, Schwarz G, Altmann H, Klewer M, Schoor M, Vonk R & Fritzemeier KH. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biology of Reproduction 2009 80 34-41.
15. Krietsch T, Fernandes MS, Kero J, Losel R, Heyens M, Lam EW, Huhtaniemi I, Brosens JJ & Gellersen B. Human homologs of the putative G protein-coupled membrane progestin receptors (mPRα, β, and γ) localize to the endoplasmic reticulum and are not activated by progesterone. Molecular Endocrinology 2006 20 3146-3164. (Pubitemid 44833562)
16. Baldi E, Luconi M, Muratori M, Marchiani S, Tamburrino L & Forti G. Nongenomic activation of spermatozoa by steroid hormones: facts and fictions. Molecular and Cellular Endocrinology 2009 308 39-46.
17. Buttgereit F. Mechanisms and clinical relevance of nongenomic glucocorticoid actions. Zeitschrift für Rheumatologie 2000 59 II/119-II/123.
18. Wanner A, Horvath G, Brieva JL, Kumar SD & Mendes ES. Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma. Proceedings of the American Thoracic Society 2004 1 235-238.
19. Belelli D, Herd MB, Mitchell EA, Peden DR, Vardy AW, Gentet L & Lambert JJ. Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 2006 138 821-829. (Pubitemid 43306821)
20. Vasudevan N & Pfaff DW. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Frontiers in Neuroendocrinology 2008 29 238-257.
21. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK & Kelly MJ. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. Journal of Neuroscience 2003 23 9529-9540. (Pubitemid 37352053)
22. Davis PJ, Zhou M, Davis FB, Lansing L, Mousa SA & Lin HY. Mini-review: cell surface receptor for thyroid hormone and nongenomic regulation of ion fluxes in excitable cells. Physiology and Behavior 2009 99 237-239.
23. Reichrath J. Will analogs of 1,25-dihydroxyvitamin D(3) (calcitriol) open a new era in cancer therapy? Onkologie 2001 24 128-133.
24. Baldi E, Casano R, Falsetti C, Krausz C, Maggi M & Forti G. Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. Journal of Andrology 1991 12 323-330.
25. Morales P, Llanos M, Gutierrez G, Kohen P, Vigil P & Vantman D. The acrosome reaction-inducing activity of individual human follicular fluid samples is highly variable and is related to the steroid content. Human Reproduction 1992 7 646-651.
26. Wehling M, Kasmayr J & Theisen K. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway? American Journal of Physiology 1991 260 E719-E726.
27. Romagni P, Rossi F, Guerrini L, Quirini C & Santiemma V. Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis 2003 166 345-349. (Pubitemid 36071693)
28. 2+ and stimulation of a plasma membrane proton conductance. PNAS 1996 93 10500-10504.
29. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG & Delyani JA. Aldosterone induces a vascular inflammatory phenotype in the rat heart. American Journal of Physiology. Heart and Circulatory Physiology 2002 283 H1802-H1810. (Pubitemid 35217013)
30. Young M, Fullerton M, Dilley R & Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. Journal of Clinical Investigation 1994 93 2578-2583.
31. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT & Weber KT. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. American Journal of Pathology 2002 161 1773-1781. (Pubitemid 35265535)
32. McEneaney V, Harvey BJ & ThomasW. Aldosterone regulates rapid trafficking of epithelial sodium channel subunits in renal cortical collecting duct cells via protein kinase D activation. Molecular Endocrinology 2008 22 881-892.
33. McEneaney V, Dooley R, Harvey BJ & ThomasW. Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation. Journal of Steroid Biochemistry and Molecular Biology 2009 118 18-28.
34. Gilligan DM, Quyyumi AA & Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994 89 2545-2551.
35. Chen DB, Bird IM, Zheng J & Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004 145 113-125. (Pubitemid 38094507)
36. Jaubert AM, Mehebik-Mojaat N, Lacasa D, Sabourault D, Giudicelli Y & Ribiere C. Nongenomic estrogen effects on nitric oxide synthase activity in rat adipocytes. Endocrinology 2007 148 2444-2452. (Pubitemid 46997057)
37. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK & Schwartz JL. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992 131 1305-1312.
38. Shears SB. Regulation of the metabolism of 1,2-diacylglycerols and inositol phosphates that respond to receptor activation. Pharmacology and Therapeutics 1991 49 79-104.
39. Eppig JJ. Intercommunication between mammalian oocytes and companion somatic cells. BioEssays 1991 13 569-574.
40. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquie M, Gauthier BR, Nef S, Stefani E & Nadal A. Pancreatic insulin content regulation by the estrogen receptor ERα. PLoS ONE 2008 3 e2069. (Pubitemid 352025028)
41. Nadal A, Rovira JM, Laribi O, Leon-quinto T, Andreu E, Ripoll C & Soria B. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB Journal 1998 12 1341-1348. (Pubitemid 28475575)
42. Soriano S, Ropero AB, Alonso-Magdalena P, Ripoll C, Quesada I, Gassner B, Kuhn M, Gustafsson JA & Nadal A. Rapid regulation of K(ATP) channel activity by 17β-estradiol in pancreatic β-cells involves the estrogen receptor β and the atrial natriuretic peptide receptor. Molecular Endocrinology 2009 23 1973-1982.
43. O'Mahony F, Alzamora R, Chung HL, Thomas W & Harvey BJ. Genomic priming of the antisecretory response to estrogen in rat distal colon throughout the estrous cycle. Molecular Endocrinology 2009 23 1885-1899.
44. O'Mahony F, Thomas W & Harvey BJ. Novel female sex-dependent actions of oestrogen in the intestine. Journal of Physiology 2009 587 5039-5044.
45. Norman AW, Olivera CJ, Barreto Silva FR & Bishop JE. A specific binding protein/receptor for 1α,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. Biochemical and Biophysical Research Communications 2002 298 414-419.
46. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP & Norman AW. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Molecular Endocrinology 2004 18 2660-2671.
47. 3 requires the presence of a functional vitamin D nuclear receptor. PNAS 2004 101 1589-1594.
48. Dixon KM, Deo SS, Norman AW, Bishop JE, Halliday GM, Reeve VE & Mason RS. In vivo relevance for photoprotection by the vitamin D rapid response pathway. Journal of Steroid Biochemistry and Molecular Biology 2007 103 451-456.
49. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L & Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008 149 558-564. (Pubitemid 351159356)
50. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. Journal of Biological Chemistry 1987 262 13168-13173.
51. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ & Davis PJ. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circulation Research 2004 94 1500-1506. (Pubitemid 38780323)
52. Davis PJ, Shih A, Lin HY, Martino LJ & Davis FB. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. Journal of Biological Chemistry 2000 275 38032-38039. (Pubitemid 32004926)
53. 2+ influx via non-genomic surface receptors in activated T cells. FEBS Letters 1997 407 211-214.
54. Lieberherr M & Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. Journal of Biological Chemistry 1994 269 7217-7223. (Pubitemid 24217910)
55. Peterziel H, Mink S, Schonert A, Becker M, Klocker H & Cato AC. Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 1999 18 6322-6329.
56. Christian HC, Rolls NJ & Morris JF. Nongenomic actions of testosterone on a subset of lactotrophs in the male rat pituitary. Endocrinology 2000 141 3111-3119.
57. Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C, Gravanis A & Castanas E. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. Journal of Clinical Endocrinology and Metabolism 2005 90 893-903.
58. Lin HY, Sun M, Lin C, Tang HY, London D, Shih A, Davis FB & Davis PJ. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-a-positive and -negative breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 2009 113 182-188.
59. Clarke RS, Dundee JW & Carson IW. Proceedings: a new steroid anaesthetic - althesin. Proceedings of the Royal Society of Medicine 1973 66 1027-1030.